Rhythm Pharmaceuticals, Inc. (RYTM) NASDAQ

50.97

+0.73(+1.45%)

Updated at March 14 04:00PM

Currency In USD

Valuation

Market Cap3.41B
Enterprise Value3.33B
P/E Ratio-11.99
PEG Ratio7.35
Price/Sales Ratio24.76
Price/Book Ratio19.08
Enterprise/Revenue24.11
Enterprise/EBITDA-13.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-2.01
Operating Margin-2.04

Management Effectiveness

Return On Assets-0.67
Return On Equity-3.79

Income Statement

Revenue130.13M
Revenue/Share2.11
Gross Profit116.76M
EBITDA-238.09M
Net Income-260.6M
Diluted EPS-4.21

Balance Sheet

Total Cash320.57M
Total Cash/Share5.2
Total Debt3.94M
Total Debt/Equity0.02
Current Ratio3.24
Book Value Per Share2.67

Price History

52-Week Change27.43
52-Week High68.58
52-Week Low35.17
Moving Average 50 Days55.93
Moving Average 200 Days51.32

Statistics

Average Volume529,023
Shares Outstanding63.22M
% Held by Institutions106.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A